Michael F. Kelley

1.7k citations

61 papers · 1.2k indexed · h-index 21

Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 5
Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 4
Linguistics and Language top 10%
Clinical Biochemistry top 10%
Immunology
Education
- Early Childhood Education and Development 7
- Child Development and Digital Technology 4
Oncology
- Drug Transport and Resistance Mechanisms 6
Developmental and Educational Psychology
- Educational and Psychological Assessments 4
Surgery
- Infectious Diseases and Tuberculosis 4
Epidemiology
- Mycobacterium research and diagnosis 3

Co-authors: Jacques Baillargeon Joseph Ilan Keith D. Boehm Dávid Paár Amy Jo Harzke Rao N. V. S. Mamidi Brad H. Pollock Charles T. Leach
Cited by: Pharmacology Infectious Diseases Linguistics and Language
Journals: Proceedings of the National Academy of Sciences (3 papers)SHILAP Revista de lepidopterología (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)
Partner nations: United States Belgium Vietnam

In The Last Decade

Michael F. Kelley

55 papers receiving 1.1k citations

Peers

Countries citing papers authored by Michael F. Kelley

Since Specialization

Citations

This map shows the geographic impact of Michael F. Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Kelley more than expected).

Fields of papers citing papers by Michael F. Kelley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Kelley. The network helps show where Michael F. Kelley may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael F. Kelley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael F. Kelley Line = papers co-authored together Michael F. Kelley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	What’s the Story with Storytime?: An Examination of Preschool Teachers’ Drama-Based and Shared Reading Practices During Picturebook Read-Aloud Early Childhood Education Journal ·Annette C. Schmidt,Melissa Pierce-Rivera,Lauren van Huisstede,Scott C. Marley,Katie A. Bernstein,Jenny Millinger,Michael F. Kelley,M. Adelaida Restrepo	2023	6
2	Preclinical safety assessment of JNJ-10450232 (NTM-006), a structural analog of acetaminophen, that does not cause hepatotoxicity at supratherapeutic doses Regulatory Toxicology and Pharmacology ·Junguo Zhou,Sandra De Jonghe,Ellen E. Codd,Sandy Weiner,David J. Gallacher,Paul L. Stahle,Michael F. Kelley,Edwin K. Kuffner,Christopher M. Flores,Gary E. Eichenbaum	2023	7
3	"We're Building Frameworks": Administrator and Educator Perspectives on Implementing a Dual Language Pre-K Program to Include All Students. Multiple Voices for Ethnically Diverse Exceptional Learners ·Kathleen M. Farrand,Megan Troxel Deeg,Sultan Kilinc,Michael F. Kelley	2019	2
4	Working Together to Prepare Teachers of Science and Language: Examining the Value of Collaboration Among Science and Language Faculty The Electronic Journal of Science Education ·Margarita Jimenez‐Silva,Joi Merritt,Peter Rillero,Michael F. Kelley	2016	7
5	Carbohydrate malabsorption mechanism for tumor formation in rats treated with the SGLT2 inhibitor canagliflozin Chemico-Biological Interactions ·Rao N. V. S. Mamidi,Jim Proctor,Sandra De Jonghe,Bianca Feyen,Esther Moesen,Petra Vinken,Ying Jing,Stewart Bryant,Sandra S. Snook,Calvert Louden,Godelieve Lammens,Kirk Ways,Michael F. Kelley,Mark D. Johnson	2014	17
6	Oxidative stress/reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants Toxicology and Applied Pharmacology ·Angelique M. Leone,Alex Nie,J. Brandon Parker,Sharmilee P. Sawant,Leigh-Anne Piechta,Michael F. Kelley,L. Mark Kao,Simon J. Proctor,Geert R. Verheyen,Mark D. Johnson,Peter G. Lord,Michael McMillian	2014	37
7	Implications of retinal effects observed in chronic toxicity studies on the clinical development of a CNS-active drug candidate Regulatory Toxicology and Pharmacology ·Gary Eichenbaum,Junguo Zhou,Michael F. Kelley,Wendy Roosen,P. Costa-Giomi,Calvert Louden,Nicholas A. Di Prospero,Gahan Pandina,Jaskaran Singh,L. Ford,John A. Moyer,T. Michael Nork,James N. Ver Hoeve,Gustavo D. Aguirre	2014	7
8	Leading Medical Causes of Mortality Among Male Prisoners in Texas, 1992—2003 Journal of Correctional Health Care ·Amy Jo Harzke,Jacques Baillargeon,Michael F. Kelley,Sandi L. Pruitt,John Pulvino,Dávid Paár	2011	10
9	Prevalence of Chronic Medical Conditions among Inmates in the Texas Prison System Journal of Urban Health ·Amy Jo Harzke,Jacques Baillargeon,Sandi L. Pruitt,John Pulvino,Dávid Paár,Michael F. Kelley	2010	76
10	Carisbamate (RWJ-333369) Neurotherapeutics ·Gerald Novak,Michael F. Kelley,Peter Zannikos,Brian D. Klein	2007	48
11	Metabolism and Excretion of RWJ-333369 [1,2-Ethanediol, 1-(2-Chlorophenyl)-, 2-carbamate, (S)-] in Mice, Rats, Rabbits, and Dogs Drug Metabolism and Disposition ·Rao N. V. S. Mamidi,Geert Mannens,Pieter Annaert,Jan Hendrickx,Ivo Goris,Mark Bockx,Cor Janssen,Mark Kao,Michael F. Kelley,W. Meuldermans	2007	12
12	Innovative Web-Based Professional Development for Teachers of At-Risk Preschool Children Educational Technology & Society ·Mable B. Kinzie,Stephen D. Whitaker,Kathy Neesen,Michael F. Kelley,Michael Matera,Robert C. Pianta	2006	27
13	The Absorption, Metabolism, and Excretion of the Novel Neuromodulator RWJ-333369 (1,2-Ethanediol, [1-2-Chlorophenyl]-, 2-carbamate, [ S ]-) in Humans Drug Metabolism and Disposition ·Geert Mannens,Jan Hendrickx,C. G. M. JANSSEN,Shuchean Chien,Bart van Hoof,Tom Verhaeghe,Mark Kao,Michael F. Kelley,Ivo Goris,Mark Bockx,B. Verreet,Meir Bialer,W. Meuldermans	2006	35
14	Pharmacokinetics, metabolism, excretion and plasma protein binding of¹⁴C-levofloxacin after a single oral administration in the Rhesus monkey Xenobiotica ·Alex Hemeryck,Rao N. V. S. Mamidi,Marco Bottacini,David Macpherson,Mark Kao,Michael F. Kelley	2006	18
15	Methicillin-Resistant Staphylococcus aureus Infection in the Texas Prison System Clinical Infectious Diseases ·Jacques Baillargeon,Michael F. Kelley,Charles T. Leach,Gwen Baillargeon,Brad H. Pollock	2004	74
16	Early Childhood Teacher Preparation and Technology Integration: The Arizona State University West Experience Contemporary issues in technology and teacher education ·Michael F. Kelley,Keith Wetzel,Helen Padgett,Mia Kim Williams,Mary Lou Odom	2003	8
17	Transmission Dynamics of Tuberculosis in Tarrant County, Texas American Journal of Respiratory and Critical Care Medicine ·Stephen E. Weis,Janice M. Pogoda,Zhenhua Yang,M. Donald Cave,Charles Wallace,Michael F. Kelley,Peter F. Barnes	2002	57
18	Management of Tuberculosis in the Texas Prison System Journal of Correctional Health Care ·Jacques Baillargeon,Michael F. Kelley,Michael J. Lichtenstein,Hal B. Jenson,Lannette C Linthicum	2002	1
19	Failure to identify non-bovine reservoirs of Mycobacterium bovis in a region with a history of infected dairy-cattle herds Preventive Veterinary Medicine ·Suresh D. Pillai,Kenneth W. Widmer,Louis J Ivey,Kevin C Coker,Everett Newman,Sonia Lingsweiler,D. Baca,Michael F. Kelley,Donald S. Davis,Nova J. Silvy,L. Garry Adams	2000	17
20	Transforming growth factor beta 1 regulates production of acute-phase proteins. Proceedings of the National Academy of Sciences ·A Mackiewicz,Mahrukh K. Ganapathi,Debra A. Schultz,A Brabenec,Jasminder Weinstein,Michael F. Kelley,Irving Kushner	1990	82

About Michael F. Kelley

Michael F. Kelley is a scholar working on Pharmacology, Developmental and Educational Psychology and Visual Arts and Performing Arts, having authored 61 papers that have together received 1.2k indexed citations. Recurring topics across this work include Early Childhood Education and Development (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), Educational and Psychological Assessments (4 papers), Tuberculosis Research and Epidemiology (4 papers), Infectious Diseases and Tuberculosis (4 papers), Child Development and Digital Technology (4 papers) and Mycobacterium research and diagnosis (3 papers). The work is most often cited by research in Pharmacology (98 citations), Infectious Diseases (196 citations) and Linguistics and Language (36 citations). Michael F. Kelley has collaborated with scholars based in United States, Belgium and Vietnam. Frequent co-authors include Jacques Baillargeon, Joseph Ilan, Keith D. Boehm, Dávid Paár, Amy Jo Harzke, Rao N. V. S. Mamidi, Brad H. Pollock, Charles T. Leach, Gwen Baillargeon and Sandi L. Pruitt. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact